| |
 |
| |
AUDITED FINANCIAL RESULTS FOR THE HALF YEAR ENDED 30TH SEPT 2008
(Rs. In Lacs) |
| Particulars |
Quarter ended |
Quarter ended |
Half Year Ended |
Half Year Ended |
Year ended |
| 30th Sept 08 |
30th Sept 07 |
30th Sept 2008 |
30th Sept 2007 |
31st Mar 2008 |
1.
|
(Gross) Sales / Income from operations |
10,337 |
8,195 |
20,714 |
15,742 |
33,585 |
| 2. |
Less : Excise Duty & Sales Tax |
923 |
789 |
1,914 |
1,596 |
2,512 |
| 3. |
(Net) Sales / Income from operations |
9,414 |
7,397 |
18,800 |
14,146 |
31,073 |
| 4. |
Other Income |
2 |
5 |
6 |
66 |
184 |
| 5. |
Total Income |
9,416 |
7,402 |
18,806 |
14,212 |
31,257 |
| |
Expenditure |
|
|
|
|
|
| |
(a) |
(Increase) / Decrease in stock in trade & WIP. |
(1,348) |
(423) |
(1,187) |
(929) |
(924) |
| |
(b) |
Consumption of raw materials. |
6,953 |
4,610 |
12,131 |
9,216 |
18,259 |
| |
(c) |
Purchase of Traded Goods |
670 |
760 |
1,520 |
1,123 |
3,892 |
| |
(d) |
Employees cost |
267 |
230 |
523 |
468 |
980 |
| |
(e) |
Depreciation |
262 |
253 |
519 |
465 |
963 |
| |
(f) |
Other expenditure |
1,476 |
1,260 |
2,778 |
2,364 |
5,119 |
| 6. |
Total Expenditure |
8,280 |
6,690 |
16,284 |
12,797 |
28,289 |
| 7. |
Interest |
604 |
201 |
1,164 |
367 |
1,184 |
| 8. |
Exceptional Items |
- |
- |
- |
- |
- |
| 9. |
Profit Before Tax (PBT) |
532 |
512 |
1,359 |
1,1049 |
1,783 |
| 10. |
Provision for Tax |
130 |
65 |
240 |
125 |
246 |
| 11. |
Profit After Tax (PAT) |
403 |
446 |
1,118 |
923 |
1,537 |
| 12. |
Provision for Deferred Tax |
63 |
43 |
125 |
100 |
230 |
| 13. |
Profit After Deferred Tax |
341 |
403 |
993 |
823 |
1,307 |
| 14. |
Extraordinary items |
- |
- |
- |
- |
- |
| 15. |
Net Profit for the period |
341 |
403 |
993 |
823 |
1,307 |
| 16. |
Paid-up Equity Share Capital of Rs.10/- each. |
1,171 |
1,171 |
1,171 |
1,171 |
1,171 |
| 17. |
Reserves & Surplus (excluding revaluation reserves) |
- |
- |
- |
- |
- |
| 18. |
Basic E P S (in Rs.) |
2.91 |
3.45 |
8.48 |
7.03 |
11.17 |
| 19. |
Diluted E P S (in Rs.) (FCCB Shares nett off) |
2.16 |
2.55 |
6.23 |
5.21 |
8.82 |
| 20. |
Aggregate of Non Promoter Shareholding |
|
|
|
|
|
| 21. |
Number of Shares |
5766044 |
6113030 |
5766044 |
6113030 |
6045866 |
| 22. |
Percentage of Total Shareholding |
49.25 |
52.21 |
49.25 |
52.21 |
51.64 |
|
| |
| Notes : |
| 1. |
There were no pending complaints at the beginning of the Quarter. During the quarter three complaintswere received and redressed. There were no complaints pending at the end of the quarter. |
| 2. |
Company is operating as a Single Segment Company, engaged in pharmaceuticals business hence, the disclosure requirement as per AS - 17 'Segment Reporting' is not attracted. |
| 3. |
The figures of the previous periods have been regrouped and rearranged wherever necessary. |
| 4. |
The above results, reviewed by the Audit Committee, have been taken on record by the Board of Directors at their meeting held on |
| For and on behalf of the Board |
| FOR AARTI DRUGS LIMITED |
| Place : Mumbai |
Harshit M Savla |
| Date : 20th Oct, 2008 |
(Jt. Managing Director) |
|
| |
| |
|
|
| |
| |
 |
| |
|
|
